PhaseBio Pharmaceuticals, Inc. (PHAS) analyst actions
Rating and price-target actions on PHAS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PHAS overview →
No PHAS analyst action events in the measured window.
Nothing matched in the current window — the PHAS overview has every event we measure for this name.
Get an email when PHAS moves on news →Keep exploring
More PHAS: earnings → · SEC filings → · PHAS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Checkpoint Therapeutics, Inc. (CKPT) | 389 | 0.00% | 49% |
| Select Medical Holdings Corporation (SEM) | 387 | -0.03% | 41% |
| ARADIGM CORP COMMON STOCK (ARDM) | 384 | 0.00% | 39% |
| HISTOGENICS CORP COMMON (HSGX) | 383 | -0.30% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.